This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Feb 28;373(9665):697-8.

doi: 10.1016/S0140-6736(09)60414-1.

Improving function: a new treatment era for multiple sclerosis?

Alan Thompson¹, Chris Polman

Affiliations

PMID: 19249614
DOI: 10.1016/S0140-6736(09)60414-1

Comment

Improving function: a new treatment era for multiple sclerosis?

Alan Thompson et al. Lancet. 2009.

. 2009 Feb 28;373(9665):697-8.

doi: 10.1016/S0140-6736(09)60414-1.

Authors

Alan Thompson¹, Chris Polman

Affiliation

¹ Institute of Neurology, University College London, London WC1N 3BG, UK. A.Thompson@ion.ucl.ac.uk

PMID: 19249614
DOI: 10.1016/S0140-6736(09)60414-1

No abstract available

PubMed Disclaimer

Comment on

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.
Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR; Fampridine MS-F203 Investigators. Goodman AD, et al. Lancet. 2009 Feb 28;373(9665):732-8. doi: 10.1016/S0140-6736(09)60442-6. Lancet. 2009. PMID: 19249634 Clinical Trial.

Similar articles

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.
Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR; Fampridine MS-F203 Investigators. Goodman AD, et al. Lancet. 2009 Feb 28;373(9665):732-8. doi: 10.1016/S0140-6736(09)60442-6. Lancet. 2009. PMID: 19249634 Clinical Trial.
Dalfampridine (Ampyra) for MS.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2010 Sep 20;52(1347):73-4. Med Lett Drugs Ther. 2010. PMID: 20847716 No abstract available.
[Fampridine and multiple sclerosis].
Mathiesen HK, Sørensen PS. Mathiesen HK, et al. Ugeskr Laeger. 2014 Jan 13;176(3A):V06130416. Ugeskr Laeger. 2014. PMID: 25347174 Review. Danish.
4-aminopyridine: new life for an old drug.
Hauser SL, Johnston SC. Hauser SL, et al. Ann Neurol. 2010 Jul;68(1):A8-9. doi: 10.1002/ana.22118. Ann Neurol. 2010. PMID: 20583227 No abstract available.
Sustained release oral fampridine in the treatment of multiple sclerosis.
Kachuck NJ. Kachuck NJ. Expert Opin Pharmacother. 2009 Aug;10(12):2025-35. doi: 10.1517/14656560903075994. Expert Opin Pharmacother. 2009. PMID: 19586420 Review.

See all similar articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information